Juncture Wealth Strategies’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,054
Closed -$280K 125
2021
Q4
$280K Sell
3,054
-1,308
-30% -$156K 0.13% 111
2021
Q3
$553K Sell
4,362
-261
-6% -$38K 0.29% 66
2021
Q2
$679K Buy
4,623
+640
+16% +$104K 0.39% 57
2021
Q1
$696K Sell
3,983
-136
-3% -$31.5K 0.44% 51
2020
Q4
$824K Sell
4,119
-421
-9% -$85.6K 0.52% 42
2020
Q3
$995K Buy
4,540
+6
+0.1% +$1.27K 0.69% 33
2020
Q2
$865K Sell
4,534
-2,611
-37% -$458K 0.65% 35
2020
Q1
$1.11M Sell
7,145
-1,113
-13% -$129K 1.02% 24
2019
Q4
$691K Sell
8,258
-382
-4% -$29.1K 0.54% 49
2019
Q3
$585K Buy
8,640
+15
+0.2% +$987 0.51% 49
2019
Q2
$573K Buy
+8,625
New +$503K 0.46% 58

Other funds holding TDOC

Juncture Wealth Strategies's TDOC Position: Q1 2022 in Review

Juncture Wealth Strategies sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 3,054 shares — an estimated $280K sold.

Juncture Wealth Strategies first reported a position in TDOC in Q2 2019 and held it in 11 quarters. The position peaked at $1.11M in Q1 2020. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Juncture Wealth Strategies reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Juncture Wealth Strategies sold 3,054 Teladoc Health shares in Q1 2022, an estimated $280K.
  • Juncture Wealth Strategies first reported a position in Teladoc Health in Q2 2019 and held it in 11 quarters.
  • Juncture Wealth Strategies's Teladoc Health position peaked at $1.11M in Q1 2020.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Juncture Wealth Strategies's 13F filing for Q1 2022, filed 14 Jul 2022.